Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-14 Sale |
2022-06-15 8:03 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
668 | $4.95 | $3,307 | 65,382 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:02 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
3,540 | $4.95 | $17,523 | 206,784 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:02 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
726 | $4.95 | $3,594 | 52,950 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:09 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
308 | $8.73 | $2,689 | 26,994 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:09 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
481 | $8.73 | $4,199 | 60,466 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:08 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
765 | $8.73 | $6,678 | 73,003 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:08 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
640 | $8.73 | $5,587 | 66,050 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:07 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
3,384 | $8.73 | $29,542 | 210,324 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:06 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
693 | $8.73 | $6,050 | 53,676 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-03 7:22 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
5,617 | $8.56 | $48,082 | 66,690 (Direct) |
View |
| 2021-09-23 Sale |
2021-09-24 10:50 am |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,451 | $17.22 | $42,206 | 33,453 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 8:03 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
859 | $15.9 | $13,655 | 10,606 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 8:02 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
1,274 | $15.9 | $20,252 | 35,636 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 8:02 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
8,009 | $15.9 | $127,312 | 99,018 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 8:01 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,444 | $15.9 | $22,954 | 17,845 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-03 Option Award |
2022-06-06 6:42 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-06 4:09 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-06 4:07 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-06 4:07 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-06 4:06 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-06 4:05 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director 10% Owner |
19,596 | $0 | 19,596 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 6:23 pm |
N/A 2032-03-01 |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
39,193 | $0 | 39,193 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:23 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
41,740 | $0 | 52,346 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:22 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
63,278 | $0 | 98,914 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:21 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
100,787 | $0 | 134,240 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:21 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
90,242 | $0 | 140,242 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:20 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
295,475 | $0 | 390,993 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:19 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
91,310 | $0 | 109,155 (Direct) |
View |
| 2021-10-01 Gift |
2021-10-04 5:03 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
3,500 | $0 | 95,518 (Direct) |
View |
| 2021-07-13 Other |
2021-07-15 4:33 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. 10% Owner |
814,013 | $0 | 8,140,130 (Direct) |
View |
| 2021-07-10 Option Award |
2021-07-13 4:22 pm |
N/A 2031-07-09 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 6:41 pm |
N/A 2031-06-01 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:43 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:38 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:38 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:38 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:38 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-27 8:37 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
19,596 | $0 | 19,596 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 7:24 pm |
N/A 2031-03-01 |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |